National Regulator Approves "Conditional Market Authorization" of Two ... - Latest Tweet by PIB India

The latest Tweet by PIB India states, 'National Regulator approves “Conditional Market Authorization” of two #COVID19Vaccines- Covaxin and Covishield Market Authorization conditional to submission of ongoing clinical trial data and safety data of the vaccine, at longer time intervals Details: ...'

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)

Share Now